BIOCELL

Scope & Guideline

Unveiling the Secrets of Cellular Innovation

Introduction

Welcome to your portal for understanding BIOCELL, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0327-9545
PublisherTECH SCIENCE PRESS
Support Open AccessNo
CountryArgentina
TypeJournal
Convergefrom 1995 to 2013, from 2015 to 2024
AbbreviationBIOCELL / Biocell
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address871 CORONADO CENTER DR, SUTE 200, HENDERSON, NV 89052

Aims and Scopes

BIOCELL is a journal dedicated to the exploration of cellular and molecular biology, emphasizing the interplay between biological systems and their microenvironments. The journal aims to publish high-quality research that elucidates mechanisms underlying cellular functions, disease processes, and therapeutic interventions.
  1. Cellular and Molecular Mechanisms:
    Research articles focusing on the intricate cellular pathways and molecular mechanisms that govern various biological processes, including cell proliferation, differentiation, apoptosis, and autophagy.
  2. Stem Cell Biology and Regenerative Medicine:
    A significant focus on the properties, applications, and therapeutic potentials of stem cells, including their roles in tissue engineering, regeneration, and treatment of various diseases.
  3. Cancer Biology and Therapeutics:
    Investigations into the molecular and cellular underpinnings of cancer, including tumor microenvironment interactions, cancer stem cells, and novel therapeutic approaches.
  4. Immunology and Host-Pathogen Interactions:
    Studies that explore the immune response to pathogens, the mechanisms of immune evasion by cancer cells, and the development of immunotherapies.
  5. Bioinformatics and Systems Biology:
    Utilization of computational methods and bioinformatics tools to analyze large datasets, identify biomarkers, and understand complex biological interactions.
  6. Nanotechnology and Biomaterials:
    Research highlighting the application of nanomaterials and biomaterials in biological systems, particularly in drug delivery, diagnostics, and tissue engineering.
BIOCELL has been progressively embracing emerging trends in research, reflecting the dynamic nature of the fields of cellular and molecular biology. The following themes have gained significant traction in recent publications.
  1. Single-Cell Sequencing and Transcriptomics:
    There is a marked increase in studies utilizing single-cell sequencing technologies to explore cellular heterogeneity and gene expression profiles, particularly in cancer and immune responses.
  2. Microbiome and Host Interactions:
    Research exploring the gut microbiome's influence on health and disease, including its interactions with host cells and implications for personalized medicine, has emerged as a key area of interest.
  3. Advancements in Nanotechnology:
    The application of nanotechnology in drug delivery systems, diagnostics, and therapeutic interventions is increasingly prominent, reflecting the journal's commitment to cutting-edge research.
  4. Cancer Immunotherapy:
    A growing body of work focuses on cancer immunotherapy, including the mechanisms of immune evasion and the development of novel immunotherapeutic strategies.
  5. Epigenetic Modifications in Health and Disease:
    There is an increasing emphasis on studies investigating the role of epigenetic changes in various diseases, including cancer and metabolic disorders, highlighting their potential as therapeutic targets.
  6. Biomaterials for Tissue Engineering:
    Research on innovative biomaterials for tissue engineering applications is gaining momentum, particularly those that enhance cellular interactions and promote regeneration.

Declining or Waning

While BIOCELL has consistently focused on several core areas, certain themes appear to be waning in prominence as the journal evolves to address emerging scientific challenges and innovations.
  1. Traditional Pharmacological Studies:
    There seems to be a decline in publications centered on classical pharmacological approaches, as the journal shifts towards more innovative and integrative methodologies.
  2. In vitro Models with Limited Relevance:
    Research utilizing simplistic in vitro models that do not adequately mimic the complexity of in vivo systems appears to be decreasing, as the field moves towards more sophisticated models, including organ-on-a-chip technologies.
  3. Basic Plant Biology Studies:
    While still relevant, there is a noticeable reduction in the number of studies solely focused on fundamental plant biology, as the journal pivots towards translational research and applications in human health.
  4. Non-targeted Metabolomics:
    The focus on non-targeted metabolomics studies has diminished, likely due to the growing emphasis on targeted approaches that yield more actionable insights in therapeutic contexts.
  5. Animal Studies with Limited Clinical Relevance:
    Research involving animal models that do not translate well to human conditions is less frequently published, reflecting a trend towards studies that emphasize translational potential.

Similar Journals

CELL DEATH AND DIFFERENTIATION

Illuminating the Pathways of Cellular Transformation
Publisher: SPRINGERNATUREISSN: 1350-9047Frequency: 12 issues/year

CELL DEATH AND DIFFERENTIATION, published by SpringerNature, is a leading peer-reviewed journal that has been at the forefront of advancing knowledge in the fields of cell biology and molecular biology since its inception in 1994. With an impressive impact factor and ranking in the Q1 quartile for both categories as of 2023, it is recognized as an essential resource for researchers and professionals dedicated to understanding the intricate processes of cellular death and differentiation. The journal publishes high-quality original research articles, reviews, and commentaries, fostering an interdisciplinary dialogue among scientists exploring the molecular mechanisms that underpin these fundamental biological processes. With its commitment to excellence, CEL DEATH AND DIFFERENTIATION bridges gaps in knowledge and stimulates innovation within the scientific community. To access cutting-edge research from this prestigious journal, you may visit their website for subscription options and explore a wealth of knowledge that is crucial for advancing the frontiers of biological research.

Cell Division

Fostering innovation in molecular biology research.
Publisher: BMCISSN: Frequency: 1 issue/year

Cell Division, an esteemed journal published by BMC, serves as a critical platform for researchers in the fields of biochemistry, cell biology, and molecular biology, showcasing groundbreaking studies and novel insights in the mechanisms governing cell division. Since its establishment in 2006, this Open Access journal, based in the United Kingdom, has strived to promote rigorous scientific discourse, ensuring unrestricted access to its rich content. With a commendable impact factor reflected in its Q1 and Q2 categorizations across various biological disciplines, Cell Division is recognized for its influence and relevance in the academic community. Targeting professionals, researchers, and students alike, it aims to disseminate high-quality research findings that further our understanding of cellular processes and contribute to advances in medical and biotechnological applications. Engage with leading-edge research and broaden your knowledge base in cell biology through this dynamic publication that continues to evolve through 2024 and beyond.

BMC Molecular and Cell Biology

Illuminating the pathways of modern biological research.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Molecular and Cell Biology is a forward-thinking open-access journal published by BMC, specializing in the vital fields of molecular biology and cell biology. Since its inception in 2019, the journal has carved a niche for itself, ranking in the Q3 quartile in both Cell Biology and Molecular Biology categories as of 2023. With an ISSN of N/A and an E-ISSN of 2661-8850, the journal provides a platform for groundbreaking research, high-quality reviews, and innovative methodologies. Situated in the United Kingdom, BMC Molecular and Cell Biology promotes a diverse range of studies, addressing fundamental questions in biology that resonate with both experts and new researchers alike. The journal's commitment to open access ensures that valuable findings are readily available to the global scientific community, fostering collaboration and knowledge-sharing across disciplines. Researchers aiming to contribute to the field of cell and molecular biology will find this journal an indispensable resource for both publishing and staying informed on the latest advances.

EXPERIMENTAL CELL RESEARCH

Fostering Collaboration in Cell Biology Research
Publisher: ELSEVIER INCISSN: 0014-4827Frequency: 20 issues/year

EXPERIMENTAL CELL RESEARCH is a highly respected journal published by Elsevier Inc, specializing in the dynamic and ever-evolving field of Cell Biology. With an impact factor positioned in the Q2 quartile for 2023, it ranks at the 124th position out of 285 in the Scopus Ranks, indicating a solid reputation among peers in the domains of biochemistry, genetics, and molecular biology. Since its inception in 1950, the journal has contributed significantly to the dissemination of groundbreaking research, providing a platform for studies that explore the nuances of cellular mechanisms, processes, and experimental methodologies. Although the journal currently does not offer open access, its commitment to high-quality, peer-reviewed research continues to attract submissions from leading scientists and scholars across the globe. Researchers, professionals, and students alike will find this journal an invaluable resource for keeping abreast of current developments and innovative breakthroughs in cellular science.

BIOSCIENCE REPORTS

Your Gateway to Cutting-Edge Scientific Discoveries
Publisher: PORTLAND PRESS LTDISSN: 0144-8463Frequency: 6 issues/year

BIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.

FEBS Journal

Catalyzing Progress in Biochemistry and Beyond
Publisher: WILEYISSN: 1742-464XFrequency: 24 issues/year

FEBS Journal is a prestigious, peer-reviewed publication dedicated to advancing the field of biochemistry, cell biology, and molecular biology. Published by WILEY in the United Kingdom, this journal boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple relevant categories, including Biochemistry, Cell Biology, and Molecular Biology, reflecting its significant contribution to scientific research. With an ISSN of 1742-464X and an E-ISSN of 1742-4658, the FEBS Journal publishes original research and comprehensive reviews that push the boundaries of knowledge and innovation in the biosciences. As a vital resource for researchers, professionals, and students alike, the journal offers Open Access options, ensuring that cutting-edge discoveries are accessible to a broad audience. With a publication history converging from 2005 to the present and a robust emphasis on high-quality scholarly work, the FEBS Journal remains an essential platform for the dissemination of significant findings and advancements in the life sciences.

GENES TO CELLS

Exploring the Interplay of Genetics and Cell Biology
Publisher: WILEYISSN: 1356-9597Frequency: 12 issues/year

GENES TO CELLS is a distinguished peer-reviewed journal published by Wiley, offering valuable insights into the intricate world of cell biology and genetics. With an ISSN of 1356-9597 and an E-ISSN of 1365-2443, this journal has been contributing to the academic community since its inception in 1996 and will continue its publishing journey until 2024. Recognized with a category quartile ranking of Q3 in both Cell Biology and Genetics, and Q2 in Medicine (Miscellaneous) as of 2023, it serves as an important platform for disseminating innovative research and reviews in molecular biology and related fields. Although it does not currently offer open access, the journal caters to a diverse readership by providing comprehensive studies that are essential for professionals, researchers, and students aiming to deepen their understanding of genetic mechanisms and cellular functions. Situated in the United Kingdom, GENES TO CELLS continues to play a pivotal role in shaping the future of biological research.

Cell Reports

Pioneering Open Access for Tomorrow's Innovations
Publisher: CELL PRESSISSN: 2211-1247Frequency: 48 issues/year

Cell Reports is a prestigious open-access journal published by CELL PRESS that has firmly established itself as a leading voice in the fields of Biochemistry, Genetics, and Molecular Biology. Since its inception in 2012, the journal has provided an innovative platform for rapid dissemination of cutting-edge research, ensuring that high-quality findings are accessible to a global audience. With an impressive impact factor and ranking within the top 10% in its category, as reflected by its Q1 ranking in Scopus, Cell Reports serves a vital role in advancing scientific knowledge and fostering collaboration among researchers. The journal's commitment to the open-access model not only enhances visibility but also encourages the sharing of critical advancements in molecular biology. Situated in the Netherlands, its contributions are recognized worldwide, making Cell Reports an indispensable resource for scientists aiming to stay at the forefront of their fields and facilitate breakthroughs that may shape the future of biomedicine.

Cell Communication and Signaling

Advancing the Frontiers of Cellular Interactions
Publisher: BMCISSN: Frequency: 1 issue/year

Cell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.

International Journal of Molecular and Cellular Medicine

Fostering Collaboration in Cutting-edge Molecular Research
Publisher: CELLULAR & MOLECULAR BIOLOGY RESEARCH CENTERISSN: 2251-9637Frequency: 4 issues/year

International Journal of Molecular and Cellular Medicine, published by the CELLULAR & MOLECULAR BIOLOGY RESEARCH CENTER in Iran, is a leading platform dedicated to advancing research in various domains of molecular and cellular sciences. With an ISSN of 2251-9637 and E-ISSN 2251-9645, this journal features a rigorous peer-review process that ensures the publication of high-quality, impactful research. Spanning from 2016 to 2024, it is categorized in the third quartile (Q3) in Biochemistry, Cell Biology, Genetics, and Molecular Biology, and second quartile (Q2) in Biotechnology, underlining its significance in the scientific community. Although currently non-open access, it maintains credible visibility through Scopus rankings, reflecting its importance in fields such as Biochemistry, Molecular Medicine, and Genetics, where it holds respectable ranks and percentiles. This journal aims to foster collaboration and knowledge dissemination among researchers, professionals, and students in the pursuit of enhancing understanding and innovation in molecular and cellular medicine.